Brevan Howard Capital Management LP Atri Cure, Inc. Transaction History
Brevan Howard Capital Management LP
- $17 Billion
- Q3 2025
A detailed history of Brevan Howard Capital Management LP transactions in Atri Cure, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 13,607 shares of ATRC stock, worth $447,670. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,607
Previous 23,529
42.17%
Holding current value
$447,670
Previous $771,000
37.87%
% of portfolio
0.0%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding ATRC
# of Institutions
243Shares Held
50.9MCall Options Held
27.1KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA4.84MShares$159 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.62MShares$152 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA4.29MShares$141 Million0.03% of portfolio
-
Alliancebernstein L.P. New York, NY3.56MShares$117 Million0.04% of portfolio
-
Hood River Capital Management LLC Palm Beach Gardens, FL3.05MShares$100 Million1.43% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.53B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...